← Back to patent-cliff list
地诺孕素/戊酸雌二醇
Tier C — Watch / tradeDienogest/Estradiol Valerate
拜耳
Originator
2010
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ERs、PR
Brand：Natazia
Indications (approved)：避孕
Regional status
US
批准上市
2010-05-06
EU
无进展
2004-04-01
China
无进展
2014-04-29
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Dienogest/Estradiol Valerate?
Approved indications include: 避孕.
When does the Dienogest/Estradiol Valerate patent expire?
No public expiry year is available for Dienogest/Estradiol Valerate yet; this page updates once verified.
How do I get a quote for Dienogest/Estradiol Valerate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24